Zealand Pharma obesity drug showed disappointing weight loss in a Phase 2 trial.
Disappointing weight-loss-drug trial results from Zealand Pharma send shares tumbling
Related Posts
Popular News
Latest News
Trump’s ‘no tax on overtime’ deduction could risk filing mistakes
Pnc | Stockbyte | Getty ImagesMillions of taxpayers have already filed to claim President Donald Trump's new "no tax on...
Ripple’s New Whitepaper Shows What’s Coming For XRP
Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure Crypto pundit X Finance Bull has drawn...
GOP ‘big beautiful bill’ to deal ‘shock’ to the ACA marketplace
J. David Ake | Getty Images News | Getty ImagesA series of policy changes in the so-called "big beautiful bill"...
Alupar 4Q25 slides: net income surges 95% despite revenue miss
Alupar 4Q25 slides: net income surges 95% despite revenue miss
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.